Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dantal

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Kidney International|September 12, 1998
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneysM Giral-Classe, M Hourmant, D Cantarovich, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1994
[Pancreatic transplantation: six years' experience CHU of Nantes]D Cantarovich, G Karam, M Hourmant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Cadaveric renal transplantation after 60 years of age. A single center experienceD Cantarovich, R Baatard, T Baranger, et al.
Annales De Pathologie|January 1, 1996
[Post-transplantation of Hodgkin's disease. Clinico-pathologic study of 3 cases]A Moreau, J Dantal, M F Heymann, et al.
Kidney International|October 10, 1998
Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantationD Cantarovich, G Karam, M Giral-Classe, et al.
La Revue De Medecine Interne|November 26, 2016
[Management of adverse effects related to human immunoglobulin therapy: Recommendations for clinical practice]I Marie, P Chérin, M Michallet, et al.
Transplantation Proceedings|February 1, 1995
Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejectionB Le Mauff, M Hourmant, Y Le Meur, et al.
Transplantation|January 1, 1994
Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantationM Hourmant, B Le Mauff, D Cantarovich, et al.
Transplantation Proceedings|February 1, 1993
Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulinD Cantarovich, M Hourmant, J Dantal, et al.
Transplantation|November 27, 1996
Anti-CD4 MoAb therapy in kidney transplantation--a pilot study in early prophylaxis of rejectionJ Dantal, E Ninin, M Hourmant, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Kidney International|September 12, 1998
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneysM Giral-Classe, M Hourmant, D Cantarovich, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1994
[Pancreatic transplantation: six years' experience CHU of Nantes]D Cantarovich, G Karam, M Hourmant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Cadaveric renal transplantation after 60 years of age. A single center experienceD Cantarovich, R Baatard, T Baranger, et al.
Annales De Pathologie|January 1, 1996
[Post-transplantation of Hodgkin's disease. Clinico-pathologic study of 3 cases]A Moreau, J Dantal, M F Heymann, et al.
Kidney International|October 10, 1998
Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantationD Cantarovich, G Karam, M Giral-Classe, et al.
La Revue De Medecine Interne|November 26, 2016
[Management of adverse effects related to human immunoglobulin therapy: Recommendations for clinical practice]I Marie, P Chérin, M Michallet, et al.
Transplantation Proceedings|February 1, 1995
Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejectionB Le Mauff, M Hourmant, Y Le Meur, et al.
Transplantation|January 1, 1994
Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantationM Hourmant, B Le Mauff, D Cantarovich, et al.
Transplantation Proceedings|February 1, 1993
Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulinD Cantarovich, M Hourmant, J Dantal, et al.
Transplantation|November 27, 1996
Anti-CD4 MoAb therapy in kidney transplantation--a pilot study in early prophylaxis of rejectionJ Dantal, E Ninin, M Hourmant, et al.
Pageof 8